Name: Nine Square Therapeutics Slogan: A quest to alter the trajectory of neurodegenerative disease Description: Founded by life sciences venture capital firm ATP and renowned scientists at the University of California San Francisco (UCSF), Nine Square is uniting machine learning-enabled image-based cell profiling, chemistry and computational sciences to develop more effective drugs, faster. They are building a diversified portfolio of first-in class drug candidates for genetically validated targets on the autophagy/lysosomal pathway to overcoming the historical challenges of treating severe neurodegenerative diseases. Currently advancing multiple programs through preclinical development, with lead optimization efforts underway towards IND-enabling studies. Founded: 2020 Industries: Biotechnology Headquarter: United States Last Investment: $4.50M grant investment at 12 September 2023 Last Investment Investors: The Michael J. Fox Foundation for Parkinson's Research
Nine Square Therapeutics, founded in 2020, is a biotechnology startup based in the United States. They are focused on developing more effective drugs for severe neurodegenerative diseases by leveraging machine learning-enabled image-based cell profiling and genetic targets on the autophagy/lysosomal pathway. The company received a $4.50M grant investment from The Michael J. Fox Foundation for Parkinson's Research in September 2023. Their approach, integrating chemistry and computational sciences, shows potential to alter the trajectory of neurodegenerative diseases.
Nine Square Therapeutics
A quest to alter the trajectory of neurodegenerative disease
South San Francisco, United States
27 employees
Grant
Total: $54.50M
Biotechnology, Health and Wellness
General Information
South San Francisco, United States
BounceWatch is an independent company data service, not affiliated with Nine Square Therapeutics. To contact Nine Square Therapeutics, visit ninesquaretx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Nine Square Therapeutics compare?
A PDF of Nine Square Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Nine Square Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Nine Square Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Nine Square Therapeutics
Business keywords: neurodegenerative disease, life sciences, venture capital, cell profiling, drug development, autophagy/lysosomal pathway, preclinical development, lead optimization, IND-enabling studies, genetic targets, computational sciences, University of California San Francisco, ATP, drug candidates
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $4.50M | 1 |
|
12 Sep 2023 |
| Series A | $50.00M | 1 |
|
01 Jul 2020 |
Nine Square Therapeutics Alternatives & Competitors
Embarking on a journey to better health through innovative biotechnology solutions for brain, geneti...
FAQ About Nine Square Therapeutics
Source: BounceWatch company record for Nine Square Therapeutics, https://bouncewatch.com/company/nine-square-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.
